BILL ANALYSIS Ó
SJR 9
Page 1
SENATE THIRD READING
SJR
9 (Stone)
As Amended June 29, 2015
Majority vote
SENATE VOTE: 37-0
SUMMARY: Urges the President and the Congress of the United
States to enact the Chronic Kidney Disease Improvement in
Research and Treatment Act (HR 1130). Makes other findings and
declarations about the prevalence, risks, and research efforts
of chronic kidney disease. This resolution declares the
following:
1)Approximately 50 years ago, kidney failure was a death
sentence.
2)In 1972, Congress developed the Medicare End-Stage Renal
Disease benefit. In doing so, Congress ensured that
regardless of age or income, any American would have access to
life-saving dialysis care. That was the turning point in
kidney care.
3)The Chronic Kidney Disease Improvement in Research and
Treatment Act (HR 1130) was introduced in the House of
Representatives by Representative Tom Marino to address kidney
disease care.
SJR 9
Page 2
4)House Resolution 1130 is built on three primary tenets. First,
for individuals living with chronic diseases, especially when
those diseases are complicated by multiple comorbid
conditions, coordinated care is key to improving outcomes and
lowering health care costs. Second, increased research can
lead to a deeper understanding of kidney disease prevention
and ultimately to significant innovations in treatment.
Lastly, stability in the Medicare program is central to an
end-stage renal disease program that ensures quality and
produces optimal results.
5)If left untreated, chronic kidney disease (CKD) can progress
to kidney failure, also known as end-stage renal disease, and
early cardiovascular death.
6)More than 20 million adults in the United States, or more than
10% of the adult population, are estimated to have CKD and
most are undiagnosed.
7)Kidney disease is the ninth leading cause of death in the
United States.
8)In the United States, diabetes and [sic] are the leading
causes of kidney failure, accounting for 72% or about three
out of four new cases of kidney failure.
9)The number of kidney failure cases in the United States
population has more than tripled since 1990 and is expected to
grow because of an aging population and the increasing number
of people with conditions, such as diabetes and high blood
pressure, that place them at the risk of developing CKD.
FISCAL EFFECT: None. This resolution is keyed non-fiscal by
SJR 9
Page 3
the Legislative Counsel.
Analysis Prepared by:
Nicole Willis / RLS. / (916) 319-2800 FN:
0001770